Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. 

Health Care

Pharmaceutical

Aquestive Therapeutics

Aquestive Therapeutics' headquarters in Warren, NJ, United States

Daniel Barber

Thomas Zalewski

Gary Slatko

Matthew Davis

Sherry Korczynski

Cassie Jung

Ernie Toth

Mark Schobel

Lori J. Braender

Peter Boyd

Tim Morris

David Golden

Jay Lieberman

Carlos Camargo

Marco Taglietti

Gregory B. Brown

John Cochran

Santo J. Costa

David M. Fleischer

David Bernstein

Matthew Greenhawt

Ruchi Gupta

John Oppenheimer

Julie Krop

This department provides expert guidance and insights to support scientific research and decision-making.

Scientific Advisory

This department oversees the organization's strategic direction and performance through effective governance and regulatory compliance.

Board Governance

The Clinical Operations and Development team at Aquestive Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials for CNS-related therapies. This team collaborates closely with cross-functional partners to ensure compliance with regulatory standards, optimize study protocols, and analyze data, ultimately driving the successful development of innovative treatments like Libervant and Sympazan. Their work is crucial in bridging the gap between preclinical research and clinical application, ensuring that promising therapies progress efficiently through the development pipeline.

Clinical Operations and Development

This department ensures the standards of quality are maintained throughout processes and products.

Quality Assurance

The Quality Assurance and Compliance team at Aquestive Therapeutics ensures that all operations and products meet stringent regulatory standards and internal quality benchmarks. This team is responsible for overseeing quality systems, pharmacovigilance, and compliance with DEA regulations, ensuring that the company’s CNS therapies are safe, effective, and compliant throughout their development and manufacturing processes. Their efforts are crucial in maintaining the integrity of the company’s products and fostering trust with stakeholders.

Quality Assurance and Compliance

This department focuses on scientific research and innovation to develop new products and technologies.

Research and Development

Aquestive Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory

Board Governance

Clinical Operations and Development

Quality Assurance

Quality Assurance and Compliance

Research and Development

Offices

Aquestive Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory

Board Governance

Clinical Operations and Development

Quality Assurance

Quality Assurance and Compliance

Research and Development

Offices

Related companies